Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

32.86
Delayed Data
As of Sep 30
 -0.19 / -0.57%
Today’s Change
26.97
Today|||52-Week Range
35.04
-3.21%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line7.7B3.3B1.2B3.1B
 
 
 
 
 
Depreciation2.3B2.7B3.1B2.7B
 
 
 
 
 
Total Other Cash Flow-2.2B1.4B282.8M-2.2B
 
 
 
 
 
Funds From Operations7.8B7.3B4.7B3.5B
 
 
 
 
 
Funds From/For Other Operating Expenses707.3M-165.5M-2.5B48.9M
 
 
 
 
 
Net Cash Flow - Operating Activities7.1B7.5B7.2B3.4B
 
 
 
 
 
 
InvestingIncrease In Investments-46.1M-90.7M-199.2M-101.8M
 
 
 
 
 
Decrease In Investments3.7B167.5M92.6M375.3M
 
 
 
 
 
Capital Expenditures-673.3M-739.8M-1.0B-1.3B
 
 
 
 
 
Fixed Asset Disposal199.4M110.7M157.4M46.9M
 
 
 
 
 
Net Assets From Acquisitions -1.2B-1.2B-4.5B-3.0B
 
 
 
 
 
Other Investing - Sources0.0034.9M0.001.1B
 
 
 
Net Cash Flow Investing-2.0B-3.0B-7.1B-4.4B
 
 
 
 
 
 
FinancingShort Term Borrowings688.3M-5.0M517.9M-628.8M
 
 
 
 
 
Long Term Borrowings2.0B0.00915.3M5.9B
 
 
 
 
Long Term Debt Reduction-1.8B-26.9M-782.8M-924.3M
 
 
 
 
 
Net Proceeds Stock Sale429.8M480.6M277.9M42.9M
 
 
 
 
 
Common Preferred Redeemed-2.6B0.000.000.00
 
 
Common Dividends-3.7B-3.5B-3.5B-3.5B
 
 
 
 
 
Cash Dividends Paid - Total-3.7B-3.5B-3.5B-3.5B
 
 
 
 
 
Other Sources - Financing48.1M0.000.000.00
 
 
Other Uses - Financing0.0035.9M115.5M0.00
 
 
 
Net Cash Flow - Financing-4.9B-3.0B-2.7B876.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-4.0M-64.8M-151.4M-75.9M
 
 
 
 
 
 
Net Change In Cash166.3M1.5B-2.7B-36.9M